scholarly journals Primary, Bilateral and Diffuse Renal Non-Hodgkin’s Lymphoma in a Young Woman Suffering from Turner Syndrome

2021 ◽  
Vol 11 (7) ◽  
pp. 644
Author(s):  
Bernardo Rossini ◽  
Tetiana Skrypets ◽  
Carla Minoia ◽  
Angela Maria Quinto ◽  
Gian Maria Zaccaria ◽  
...  
Keyword(s):  
Lymph Node ◽  
Rare Disease ◽  
Turner Syndrome ◽  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma ◽  
Rare Form ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Extranodal Lymphomas ◽  
Personalized Approach

Primary renal lymphoma (PRL) is a rare form of non-Hodgkin’s lymphoma (NHL) restricted to and primarily involving one or both kidneys, with no lymph node extension. It accounts for <1% of extranodal lymphomas, and descriptions in the literature are limited. Here, we describe an unprecedented case of bilateral PRL in a 44-year-old woman with Turner syndrome and discuss both diagnostic and therapeutic issues in the light of the available literature in the field. A personalized approach to this rare disease is necessary.

scholarly journals Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non- Hodgkin's lymphoma

Blood ◽  
1993 ◽  
Vol 82 (8) ◽  
pp. 2510-2516 ◽  
Author(s):  
AC Lambrechts ◽  
PE Hupkes ◽  
LC Dorssers ◽  
MB van't Veer
Keyword(s):  
Bone Marrow ◽  
Lymph Node ◽  
Peripheral Blood ◽  
Hodgkin’S Lymphoma ◽  
Lymph Node Biopsy ◽  
Stage I ◽  
Hodgkin's Lymphoma ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Sensitive Polymerase Chain Reaction

Abstract Stage I and II follicular non-Hodgkin's lymphoma (NHL) is clinically defined as a localized disease. To study the possibility that this disease is in fact disseminated, we used the sensitive polymerase chain reaction (PCR) method using translocation (14;18) as marker. Samples from 21 patients who were clinically diagnosed with stage I or II follicular NHL were analyzed for the presence of t(14;18)-positive cells using PCR. We analyzed (1) the diagnostic lymph node biopsy and (2) the peripheral blood or bone marrow samples from these patients. Translocation (14;18) cells were detected in the diagnostic lymph node biopsies of 12 patients. In 9 of these patients, t(14;18)-positive cells were detected in peripheral blood and/or bone marrow samples at diagnosis and/or after therapy. Thus, in 75% of the follicular NHL patients carrying the t(14;18) as a marker for lymphoma cells, t(14;18)- positive cells were detected in peripheral blood and bone marrow at diagnosis and after therapy. Our results show that t(14;18)-positive cells can be detected in the circulation of patients with stage I and II follicular NHL, indicating that, although diagnosed as localized, the disease is disseminated.

Primary laryngeal lymphoma in China: a retrospective study of the last 25 years

2019 ◽  
Vol 133 (09) ◽  
pp. 792-795
Author(s):  
P Zhao ◽  
Y Zhou ◽  
J Li
Keyword(s):  
Lymph Node ◽  
T Cell ◽  
Hodgkin’S Lymphoma ◽  
Chinese Language ◽  
Lymph Node Involvement ◽  
Hodgkin's Lymphoma ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Node Involvement ◽  
Language Literature

AbstractObjectiveTo retrospectively study the primary laryngeal lymphoma cases in China reported in Chinese-language literature.MethodChinese-language literature was searched for papers on primary laryngeal lymphoma published in the last 25 years.ResultsThe selected papers comprised a total of 115 cases. The male-to-female ratio was 3.4:1. Non-Hodgkin's lymphoma was the exclusive pathological type. The estimated 3-year, 5-year and 10-year survival rates were 70.9 ± 6.4 per cent, 63.4 ± 7.6 per cent and 56.4 ± 9.5 per cent respectively, as determined by Kaplan–Meier analysis. B-cell non-Hodgkin's lymphoma patients had a better prognosis than T-cell non-Hodgkin's lymphoma patients (p = 0.032). Patients with lymph node involvement at diagnosis had a poorer prognosis (p &lt; 0.01).ConclusionPrimary laryngeal lymphoma is a rare disease with no specific clinical features. More than one biopsy might be needed to obtain the correct diagnosis. Proper treatment could lead to promising outcomes. The T-cell subtype and lymph node involvement at diagnosis might indicate worse prognosis.

Primary non-Hodgkin's lymphoma arising in an intramammary lymph node

2005 ◽  
Vol 46 (3) ◽  
pp. 451-455 ◽  
Author(s):  
Ioannis Venizelos ◽  
Zoi Tatsiou ◽  
Sofia Vakalopoulou ◽  
Eudokia Mandala ◽  
Vasiliki Garipidou
Keyword(s):  
Lymph Node ◽  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Intramammary Lymph Node

Ki-67 Proliferative Marker in Lymph Node Aspirates of Patients with Non-Hodgkin's Lymphoma

2006 ◽  
Vol 23 (1) ◽  
pp. 83-90 ◽  
Author(s):  
B. Mihaljevic ◽  
R. Nedeljkov-Jancic ◽  
V. Cemerikic-Martinovic ◽  
D. Babic ◽  
M. Colovic
Keyword(s):  
Lymph Node ◽  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma ◽  
Ki 67 ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Proliferative Marker

Automated Cytochemistry in Non-Hodgkin’s Lymphoma: A New Method for Determination of Cells from Lymph Node Biopsy

1986 ◽  
Vol 75 (4) ◽  
pp. 199-202
Author(s):  
Ahnond Bunyaratvej ◽  
Pattraporn Boonkanta ◽  
Prawat Nítiyanant ◽  
Suntaree Apibal ◽  
Natth Bhamarapravati
Keyword(s):  
Lymph Node ◽  
Hodgkin’S Lymphoma ◽  
Lymph Node Biopsy ◽  
New Method ◽  
Hodgkin's Lymphoma ◽  
Node Biopsy ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma

scholarly journals Prognostic value of cytophotometric analysis of DNA in lymph node aspirates from patients with non-Hodgkin's lymphoma.

1990 ◽  
Vol 43 (8) ◽  
pp. 626-629 ◽  
Author(s):  
J Vuckovic ◽  
M Dubravcic ◽  
J M Matthews ◽  
S N Wickramasinghe ◽  
M Dominis ◽  
...  
Keyword(s):  
Lymph Node ◽  
Prognostic Value ◽  
Hodgkin’S Lymphoma ◽  
Hodgkin's Lymphoma ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Cytophotometric Analysis
Sign in / Sign up

Export Citation Format

Share Document